YOU LOVE TO SEE IT: Clean Energy Carries On
Clean energy money stays in clean hands, reproductive health is shielded from harm, Big Landlord takes a hit, and geothermal energy pumps up the heat.
Business
Critical coverage on the global financial system and domestic policies that shape the U.S. economy, with a focus on corporate wrongdoing.
Wall Street Is Jacking Up The Cost Of Your Doctor Visits
A groundbreaking study finds doctors affiliated with hospitals and private equity firms are charging billions more annually than independent general practitioners.
YOU LOVE TO SEE IT: The Big Court Rejects Big Oil’s Accountability Dodge
Climate killers head to trial, an oasis forms in an abortion desert, students score another payday, and the Golden State gets golden laws.
The Dark Money Plan To Spend Your Tax Dollars On Bitcoin
Fossil fuel operatives are pushing Trump and state governments to buy billions of a volatile cryptocurrency, jeopardizing taxpayer dollars and the environment alike.
We Will All Be Paying For L.A.’s Wildfires
Los Angeles’ wildfires and an industry-tied insurance regulator may prove a tipping point for the country’s faltering financial safety net.
Drug Commercials Aren’t Just Annoying — They’re Costing You Money
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
YOU LOVE TO SEE IT: In With The Good Energy, Out With The Bad
California looks to the renewable future, while New York probes the polluted past.
The Rise Of Big Potato
Allegations of price collusions among the potato cartel reveal the new, sophisticated methods food corporations are using to keep prices high.
Floods: An Impending Partisan Disaster
A new Fed study warns that most expected flood losses are uninsured — and the lack of protection is more acute among Republican locales.
The McKinsey Opioid Consultants Who Got Away
The Biden administration just delivered a sweetheart deal to its friends at McKinsey, letting the consulting giant off the hook for helping to “turbocharge” disastrous OxyContin sales.